<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Kozai, Toshiyuki</dc:creator>
  <dc:creator>Eto, Masato</dc:creator>
  <dc:creator>Yang, Zhihong</dc:creator>
  <dc:creator>Shimokawa, Hiroaki</dc:creator>
  <dc:creator>Lüscher, Thomas F.</dc:creator>
  <dc:date>2005-08-11</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">&lt;p&gt;Objective:&lt;/p&gt; Pulsatile forces regulate vascular remodeling and trigger vascular  diseases such as saphenous vein graft disease. The saphenous vein is exposed to  high pressure and pulsatility only after implantation. Statins have been proved to  reduce the incidence of vein graft failure. Thus, we investigated the molecular  mechanisms of pulsatile stretch-induced saphenous vein smooth muscle cell (SMC)  proliferation and potential beneficial effects of statins. &lt;p&gt;Methods and results:&lt;/p&gt;  Human saphenous vein SMCs were subjected to cyclic stretch (60 cycles/min) in Flex  I plates. Cerivastatin and simvastatin significantly prevented stretch-induced increase  in SMC proliferation. Stretch induced the membrane accumulation of Rho A and Rho  kinase inhibitors (Y-27632 and hydroxyfasudil) and dominant negative Rho A mutant  significantly prevented stretch-induced SMC proliferation. In addition, stretch  increased the levels of both p44/42 mitogen-activated protein (MAP) kinase and Akt  phosphorylation. MAP kinase kinase (MEK)1/2 inhibitor U0126, phosphatidylinositol  (PI) 3-kinase inhibitors (wortmaninn and LY294002), and dominant negative Akt  mutant significantly prevented stretch-induced SMC proliferation. Cerivastatin  significantly prevented stretch-induced membrane accumulation of Rho A. On the  other hand, stretch-induced phosphorylation of p44/42 MAP kinase and Akt was not  prevented by cerivastatin. Mevalonate restored the preventive effect of cerivasatain on  stretch-induced Rho A membrane accumulation. Stretch induced  hyperphosphorylation of retinoblastoma protein (pRb), which was prevented by  cerivastatin and the Rho kinase inhibitors. &lt;p&gt;Conclusion :&lt;/p&gt;Statins prevent  stretch-induced saphenous vein SMC proliferation via inhibition of the Rho/Rho-kinase  pathway. This may explain the beneficial effects of this class of drug, especially for  patients after coronary artery bypass grafting.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/300066</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/300066/files/68-3-475.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cardiores.2005.07.002</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Cardiovascular Research. - 2005, vol. 68, no. 3, p. 475-482</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">stretch</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">SMC proliferation</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">stains</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns4="xml" ns4:lang="en">Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
